Michael Hulse

701 total citations
17 papers, 462 citations indexed

About

Michael Hulse is a scholar working on Oncology, Molecular Biology and Plant Science. According to data from OpenAlex, Michael Hulse has authored 17 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Plant Science. Recurrent topics in Michael Hulse's work include Viral-associated cancers and disorders (5 papers), PARP inhibition in cancer therapy (5 papers) and DNA Repair Mechanisms (3 papers). Michael Hulse is often cited by papers focused on Viral-associated cancers and disorders (5 papers), PARP inhibition in cancer therapy (5 papers) and DNA Repair Mechanisms (3 papers). Michael Hulse collaborates with scholars based in United States, Poland and Italy. Michael Hulse's co-authors include Italo Tempera, Lisa Beatrice Caruso, Stuart Johnson, Patricia Ferrieri, Yinfei Tan, Jozef Madžo, Kayla Martin, Sarah Johnson, Gene D. Schroder and Carl S. Hacker and has published in prestigious journals such as Nature Communications, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

Michael Hulse

15 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hulse United States 12 195 186 73 62 57 17 462
Mark de Jong Netherlands 13 250 1.3× 62 0.3× 36 0.5× 22 0.4× 56 1.0× 21 554
Ju Ock Kim South Korea 10 170 0.9× 118 0.6× 68 0.9× 38 0.6× 31 0.5× 48 477
Edwin Yau United States 12 309 1.6× 82 0.4× 54 0.7× 98 1.6× 106 1.9× 31 547
Chang Zheng China 11 199 1.0× 80 0.4× 47 0.6× 96 1.5× 32 0.6× 26 400
Ziv Sevilya Israel 10 369 1.9× 94 0.5× 45 0.6× 22 0.4× 104 1.8× 19 530
Kamila Chagas Peronni Brazil 11 139 0.7× 30 0.2× 72 1.0× 67 1.1× 83 1.5× 23 332
Miranda L. Hanson United States 6 117 0.6× 88 0.5× 26 0.4× 201 3.2× 14 0.2× 9 469
Yin Zhu China 14 296 1.5× 137 0.7× 43 0.6× 55 0.9× 45 0.8× 26 570
Nicole Paland Israel 10 199 1.0× 104 0.6× 68 0.9× 145 2.3× 73 1.3× 14 477
Qianyu Chen China 11 98 0.5× 50 0.3× 32 0.4× 65 1.0× 18 0.3× 38 392

Countries citing papers authored by Michael Hulse

Since Specialization
Citations

This map shows the geographic impact of Michael Hulse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hulse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hulse more than expected).

Fields of papers citing papers by Michael Hulse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hulse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hulse. The network helps show where Michael Hulse may publish in the future.

Co-authorship network of co-authors of Michael Hulse

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hulse. A scholar is included among the top collaborators of Michael Hulse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hulse. Michael Hulse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hulse, Michael, et al.. (2023). PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies. Cancer Research Communications. 3(11). 2233–2243. 15 indexed citations
2.
Miller, Katelyn D., Seamus O’Connor, Toshitha Kannan, et al.. (2023). Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer. Nature Cancer. 4(10). 1491–1507. 78 indexed citations
3.
Tanizawa, Hideki, Lisa Beatrice Caruso, Michael Hulse, et al.. (2022). The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity. Nature Communications. 13(1). 187–187. 37 indexed citations
4.
Hulse, Michael. (2020). REGULATION OF CELLULAR GENE EXPRESSION AND METABOLISM BY EPSTEIN-BARR VIRUS LATENT MEMBRANE PROTEIN 1. TUScholarShare (Temple University). 1 indexed citations
5.
Hulse, Michael, Sarah Johnson, Sarah A. Boyle, Lisa Beatrice Caruso, & Italo Tempera. (2020). Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase. Journal of Virology. 95(4). 40 indexed citations
6.
Hulse, Michael, Lisa Beatrice Caruso, Jozef Madžo, et al.. (2018). Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1. PLoS Pathogens. 14(11). e1007394–e1007394. 32 indexed citations
7.
Caruso, Lisa Beatrice, Jozef Madžo, Kayla Martin, et al.. (2018). PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type. Journal of Virology. 92(18). 40 indexed citations
8.
Caruso, Lisa Beatrice, Kayla Martin, Elisabetta Lauretti, et al.. (2018). Poly(ADP-ribose) Polymerase 1, PARP1, modifies EZH2 and inhibits EZH2 histone methyltransferase activity after DNA damage. Oncotarget. 9(12). 10585–10605. 29 indexed citations
9.
Maifrede, Silvia, Kayla Martin, Paulina Podszywalow‐Bartnicka, et al.. (2017). IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors. Molecular Cancer Research. 15(8). 967–972. 19 indexed citations
10.
Moquin, Stephanie, Kayla Martin, Shane McDevitt, et al.. (2017). PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter. Virology. 507. 220–230. 35 indexed citations
11.
Maifrede, Silvia, Esteban Martı́nez, Margaret Nieborowska-Skorska, et al.. (2017). MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs. Blood Advances. 1(19). 1467–1472. 21 indexed citations
12.
Savi, Chris De, Robert H. Bradbury, Alfred A. Rabow, et al.. (2015). Abstract 3650: Discovery of the clinical candidate AZD9496: a potent and orally bioavailable selective estrogen receptor downregulator and antagonist. Cancer Research. 75(15_Supplement). 3650–3650. 4 indexed citations
13.
Hulse, Michael, Stuart Johnson, & Patricia Ferrieri. (1993). Agrobacterium Infections in Humans: Experience at One Hospital and Review. Clinical Infectious Diseases. 16(1). 112–117. 51 indexed citations
14.
Hulse, Michael, et al.. (1980). Environmentally acquired lead, cadmium, and manganese in the cattle egret,Bubulcus ibis, and the laughing gull,Larus atricilla. Archives of Environmental Contamination and Toxicology. 9(1). 65–77. 59 indexed citations
15.
Auken, O. W. Van & Michael Hulse. (1978). Translocation and Metabolism of Leaf Applied Hexachlorophene in Peanuts. Physiologia Plantarum. 44(3). 205–214.
16.
Auken, O. W. Van & Michael Hulse. (1977). Extraction and Gas-Liquid Chromatographic Determination of Hexachlorophene from Several Plant Tissues. Journal of AOAC INTERNATIONAL. 60(5). 1081–1086.
17.
Auken, O. W. Van, et al.. (1977). Extraction, Gas-Liquid Chromatographic Detection, and Quantitation of Hexachlorophene Residues from Plant Tissues High in Lipid Content. Journal of AOAC INTERNATIONAL. 60(5). 1087–1092. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark de Jong Breakdown of academic impact, for papers by Ju Ock Kim Breakdown of academic impact, for papers by Edwin Yau Breakdown of academic impact, for papers by Chang Zheng Breakdown of academic impact, for papers by Ziv Sevilya Breakdown of academic impact, for papers by Kamila Chagas Peronni Breakdown of academic impact, for papers by Miranda L. Hanson Breakdown of academic impact, for papers by Yin Zhu Breakdown of academic impact, for papers by Nicole Paland Breakdown of academic impact, for papers by Qianyu Chen
Rankless by CCL
2026